CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Firefly Neuroscience Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Firefly Neuroscience Inc
1100 Military Road
Phone: (302) 658-7581p:302 658-7581 KENMORE, NY  14217  United States Ticker: AIFFAIFF
Business Summary
Firefly Neuroscience, Inc. is an artificial intelligence (AI) company advancing precision neuroscience. The Company's BNA Platform and Evoke System are Class II medical devices, which were cleared by FDA for commercialization. The Company's FDA-510(k) cleared Evoke System, commercially deployed as the Evoke System, is in active use over 85 clinical sites in the United States. The Company has developed Firefly Platform, a vertically integrated hardware, software, and data infrastructure that captures standardized electroencephalographic (EEG) and event-related potential (ERP) assessments at the point of care, analyzes that data through its proprietary analytics engine, and delivers structured, clinician-ready reports back to the provider, all within a single seamless workflow. Its proprietary analytics engine analyzes raw EEG and ERP signals across captured dimensions and compares each patient’s electrophysiological profile to a reference dataset.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes--Yes

Industries
SIC Code Description
7372 Prepackaged software
7371 Computer programming services
7373 Computer integrated systems design

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Arun S.Menawat 70 3/10/2025 8/12/2024
President, Chief Operating Officer, Director DavidDecaprio 52 4/18/2025 8/12/2024
Chief Executive Officer, Director GregLipschitz 36 3/26/2025 8/12/2024
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Evoke Neuroscience, Inc 1115 Broadway, 12th Floor New York NY United States

Business Names
Business Name
AIFF
Elminda 2022 Inc.
Elminda Canada Inc.
11 additional Business Names available in full report.

General Information
Number of Employees: 17 (As of 12/31/2025)
Outstanding Shares: 14,793,075 (As of 3/25/2026)
Shareholders: 354
Stock Exchange: NASD
Federal Tax Id: 541167364
Fax Number: (302) 655-5049
Email Address: info@fireflyneuro.com


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 12, 2026